Literature DB >> 27449413

Invited Commentary: Influenza, Influenza Immunization, and Pregnancy-It's About Time.

Jennifer A Hutcheon, David A Savitz.   

Abstract

Immunization of pregnant women against influenza has the potential to reduce adverse fetal outcomes by reducing prenatal exposure to influenza illness. However, as touched on by Fell et al. (Am J Epidemiol. 2016;184(3):163-175) and Vazquez-Benitez et al. (Am J Epidemiol. 2016;184(3):176-186) in this issue of the Journal, observational studies in which the causal effect of maternal influenza illness and influenza immunization on fetal health are evaluated are prone to bias because of the complex temporal nature of influenza illness seasonality, influenza immunization schedules, and gestation itself. Immortal time bias is introduced by an "anytime-in-pregnancy" exposure definition because the shortened pregnancy duration associated with many adverse fetal outcomes limits the opportunity to become exposed, whereas including follow-up time during which pregnancies are no longer at risk of an adverse outcome (e.g., gestational time after 37 weeks in studies of preterm birth) can lead to overestimation of any true benefits of immunization (or harms from influenza illness). We present a framework to avoid time-related biases in the study of influenza illness and immunization in pregnancy and advise that investigations of fetal benefit from maternal influenza immunization should only be undertaken when information is available on the calendar time of influenza virus circulation and the gestational age at which maternal influenza immunization occurred.
© The Author 2016. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  gestational duration; immortal time bias; influenza illness; influenza immunization; pregnancy; preterm birth; seasonality; stillbirth

Mesh:

Year:  2016        PMID: 27449413      PMCID: PMC4967596          DOI: 10.1093/aje/kww042

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  20 in total

1.  Immortal time bias in observational studies of drug effects in pregnancy.

Authors:  Ilan Matok; Laurent Azoulay; Hui Yin; Samy Suissa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-07-01

2.  Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure.

Authors:  Sharon Daniel; Gideon Koren; Eitan Lunenfeld; Amalia Levy
Journal:  Am J Obstet Gynecol       Date:  2014-10-12       Impact factor: 8.661

3.  Influenza vaccination of pregnant women and protection of their infants.

Authors:  Shabir A Madhi; Clare L Cutland; Locadiah Kuwanda; Adriana Weinberg; Andrea Hugo; Stephanie Jones; Peter V Adrian; Nadia van Niekerk; Florette Treurnicht; Justin R Ortiz; Marietjie Venter; Avy Violari; Kathleen M Neuzil; Eric A F Simões; Keith P Klugman; Marta C Nunes
Journal:  N Engl J Med       Date:  2014-09-04       Impact factor: 91.245

4.  Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial.

Authors:  Mark C Steinhoff; Saad B Omer; Eliza Roy; Shams El Arifeen; Rubhana Raqib; Caitlin Dodd; Robert F Breiman; K Zaman
Journal:  CMAJ       Date:  2012-02-21       Impact factor: 8.262

5.  Immortal time bias in the study of stillbirth risk factors: the example of gestational diabetes.

Authors:  Jennifer A Hutcheon; Verena Kuret; K S Joseph; Yasser Sabr; Kenneth Lim
Journal:  Epidemiology       Date:  2013-11       Impact factor: 4.822

6.  Risk of Preterm or Small-for-Gestational-Age Birth After Influenza Vaccination During Pregnancy: Caveats When Conducting Retrospective Observational Studies.

Authors:  Gabriela Vazquez-Benitez; Elyse O Kharbanda; Allison L Naleway; Heather Lipkind; Lakshmi Sukumaran; Natalie L McCarthy; Saad B Omer; Lei Qian; Stanley Xu; Michael L Jackson; Vinutha Vijayadev; Nicola P Klein; James D Nordin
Journal:  Am J Epidemiol       Date:  2016-07-22       Impact factor: 4.897

7.  Low birthweight at term and the timing of fetal exposure to maternal smoking.

Authors:  E Lieberman; I Gremy; J M Lang; A P Cohen
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

Review 8.  A global perspective of maternal influenza immunization.

Authors:  Philipp Lambach; Joachim Hombach; Justin R Ortiz
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

9.  Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study.

Authors:  Saad B Omer; David Goodman; Mark C Steinhoff; Roger Rochat; Keith P Klugman; Barbara J Stoll; Usha Ramakrishnan
Journal:  PLoS Med       Date:  2011-05-31       Impact factor: 11.069

10.  Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Sonja J Olsen; Joseph S Bresee; Karen R Broder; Ruth A Karron
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-08-07       Impact factor: 17.586

View more
  11 in total

1.  Safety, equity and monitoring: a review of the gaps in maternal vaccination strategies for Aboriginal and Torres Strait Islander women.

Authors:  Lisa McHugh; Kristy Crooks; Amy Creighton; Michael Binks; Ross M Andrews
Journal:  Hum Vaccin Immunother       Date:  2019-09-06       Impact factor: 3.452

2.  Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: A systematic review and meta-analysis.

Authors:  Marta C Nunes; Shabir A Madhi
Journal:  Hum Vaccin Immunother       Date:  2017-10-18       Impact factor: 3.452

3.  Challenges in estimating influenza vaccine effectiveness.

Authors:  Kylie E C Ainslie; Michael Haber; Walt A Orenstein
Journal:  Expert Rev Vaccines       Date:  2019-05-31       Impact factor: 5.217

4.  Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015.

Authors:  Deshayne B Fell; Zulfiqar A Bhutta; Jennifer A Hutcheon; Ruth A Karron; Marian Knight; Michael S Kramer; Arnold S Monto; Geeta K Swamy; Justin R Ortiz; David A Savitz
Journal:  Vaccine       Date:  2017-03-24       Impact factor: 3.641

5.  Safety and protective effects of maternal influenza vaccination on pregnancy and birth outcomes: A prospective cohort study.

Authors:  Hassen Mohammed; Claire T Roberts; Luke E Grzeskowiak; Lynne C Giles; Gustaaf A Dekker; Helen S Marshall
Journal:  EClinicalMedicine       Date:  2020-09-09

6.  The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.

Authors:  Lara S Lemon; Ashley Naimi; Steve N Caritis; Robert W Platt; Raman Venkataramanan; Lisa M Bodnar
Journal:  Paediatr Perinat Epidemiol       Date:  2018-01-26       Impact factor: 3.980

7.  Hutcheon et al. Respond to "Maternal Influenza Immunization and Birth Outcomes".

Authors:  Jennifer A Hutcheon; Deshayne B Fell; Michael L Jackson; Michael S Kramer; Justin R Ortiz; David A Savitz; Robert W Platt
Journal:  Am J Epidemiol       Date:  2016-10-26       Impact factor: 4.897

8.  Maternal Influenza Immunization and Adverse Birth Outcomes: Using Data and Practice to Inform Theory and Research Design.

Authors:  Varun K Phadke; Mark C Steinhoff; Saad B Omer; Noni E MacDonald
Journal:  Am J Epidemiol       Date:  2016-10-26       Impact factor: 4.897

9.  Measurement of birth outcomes in analyses of the impact of maternal influenza vaccination.

Authors:  Melissa A Rolfes; Phouvanh Vonglokham; Viengphone Khanthamaly; Bounlap Chitry; Vathsana Pholsena; Visith Chitranondh; Sara A Mirza; Ann Moen; Joseph S Bresee; Anonh Xeuatvongsa; Sonja J Olsen
Journal:  Influenza Other Respir Viruses       Date:  2019-08-19       Impact factor: 4.380

10.  Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group.

Authors:  Deshayne B Fell; Eduardo Azziz-Baumgartner; Michael G Baker; Maneesh Batra; Julien Beauté; Philippe Beutels; Niranjan Bhat; Zulfiqar A Bhutta; Cheryl Cohen; Bremen De Mucio; Bradford D Gessner; Michael G Gravett; Mark A Katz; Marian Knight; Vernon J Lee; Mark Loeb; Johannes M Luteijn; Helen Marshall; Harish Nair; Kevin Pottie; Rehana A Salam; David A Savitz; Suzanne J Serruya; Becky Skidmore; Justin R Ortiz
Journal:  Vaccine       Date:  2017-09-01       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.